Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Preparing the future. Those three words describe Dr. James Maiarana's experience at NIH as a clinical fellow at National Cancer Institute. The opportunity to work side-by-side with experts who are advancing the future of medicine creates an unmatched environment for learning, discovery, and career development. Learn more about NCI... show more

NIH

1,748,659 subscribers

13,593 views • 8 days ago •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

1 Comments

Yahya A. Mumin8 days ago

@theNCI Hoping to have an opportunity like this one day, to learn from leading experts and contribute to medical research. 🔬🩺

Related Videos

Why choose NIH for your clinical fellowship? Dr. Derek MacMath, a Clinical Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), values the close proximity to the NIH Clinical Center and the unique opportunity to conduct translational research. See why NIH is an exceptional place to train, collaborate, and make an impact. Learn more about NIAID Clinical Fellowship opportunities:

Why choose NIH for your clinical fellowship? Dr. Derek MacMath, a Clinical Fellow at the National Institute of Allergy and Infectious Diseases (NIAID), values the close proximity to the NIH Clinical Center and the unique opportunity to conduct translational research. See why NIH is an exceptional place to train, collaborate, and make an impact. Learn more about NIAID Clinical Fellowship opportunities:

NIH

13,192 views • 1 month ago

Looking for more out of your fellowship? Dr. Rachel Strength shares how her favorite part of being a clinical fellow at NIH is the relationships she’s built with mentors and patients. Learn more about how you can get more out of your fellowship experience, build connections, collaborate across disciplines, and grow your career in an environment designed for impact with NIAID Clinical Fellowship Opportunities:

Looking for more out of your fellowship? Dr. Rachel Strength shares how her favorite part of being a clinical fellow at NIH is the relationships she’s built with mentors and patients. Learn more about how you can get more out of your fellowship experience, build connections, collaborate across disciplines, and grow your career in an environment designed for impact with NIAID Clinical Fellowship Opportunities:

NIH

22,007 views • 1 month ago

A hallway conversation can turn into a valuable scientific collaboration at NIH. Clinical fellows like Dr. William Hayward have the chance to care for patients participating in cutting-edge research studies, with resources often unavailable anywhere else. It’s medicine at the frontier, where every case contributes to new knowledge. Learn more about NINDS Clinical Fellowship opportunities:

A hallway conversation can turn into a valuable scientific collaboration at NIH. Clinical fellows like Dr. William Hayward have the chance to care for patients participating in cutting-edge research studies, with resources often unavailable anywhere else. It’s medicine at the frontier, where every case contributes to new knowledge. Learn more about NINDS Clinical Fellowship opportunities:

NIH

14,207 views • 2 days ago

It is because of the gold standard research conducted at NIH that children with rare diseases are provided the opportunity of lifesaving therapies and treatments. We are proud of our friends at FDA launching a framework for accelerating the development of individualized therapies for ultra rare diseases. Read more about FDA’s plan to accelerate cures here ➡️ HHS

It is because of the gold standard research conducted at NIH that children with rare diseases are provided the opportunity of lifesaving therapies and treatments. We are proud of our friends at FDA launching a framework for accelerating the development of individualized therapies for ultra rare diseases. Read more about FDA’s plan to accelerate cures here ➡️ HHS

NIH

22,610 views • 7 months ago

For decades, the National Cancer Institute, or NCI, has spearheaded breakthrough advancements against the disease. Since the 1990s, cancer deaths have been reduced by a third. But now, the world's premier cancer institute is in the midst of a fierce battle over its future. William Brangham sat down with Rachana D. Pradhan of KFF Health News to learn more.

For decades, the National Cancer Institute, or NCI, has spearheaded breakthrough advancements against the disease. Since the 1990s, cancer deaths have been reduced by a third. But now, the world's premier cancer institute is in the midst of a fierce battle over its future. William Brangham sat down with Rachana D. Pradhan of KFF Health News to learn more.

PBS News

15,072 views • 1 year ago

On Friday, Dr. Letai of the National Cancer Institute and I joined Chris Cuomo for NewsNation’s town hall, “Why Can’t We Cure Cancer?” The special gave us an opportunity to discuss the groundbreaking work underway at NIH, including advances in immunotherapy and innovative efforts to repurpose existing cancer drugs. NIH continues to lead the charge with gold-standard science, driving the discovery of new therapies and moving us closer to cures for cancer and other chronic diseases. To watch the full special take a look ➡️

On Friday, Dr. Letai of the National Cancer Institute and I joined Chris Cuomo for NewsNation’s town hall, “Why Can’t We Cure Cancer?” The special gave us an opportunity to discuss the groundbreaking work underway at NIH, including advances in immunotherapy and innovative efforts to repurpose existing cancer drugs. NIH continues to lead the charge with gold-standard science, driving the discovery of new therapies and moving us closer to cures for cancer and other chronic diseases. To watch the full special take a look ➡️

Jay Bhattacharya, MD, PhD

25,458 views • 6 months ago

What does it take to turn a discovery into a breakthrough? Decades of diligent work. NIH vision scientist Dr. Michael Redmond’s life’s work led to the discovery of a gene associated with a retinal dystrophy that causes blindness. Read how this discovery paved the way for an FDA-approved gene therapy to treat the disease:

What does it take to turn a discovery into a breakthrough? Decades of diligent work. NIH vision scientist Dr. Michael Redmond’s life’s work led to the discovery of a gene associated with a retinal dystrophy that causes blindness. Read how this discovery paved the way for an FDA-approved gene therapy to treat the disease:

NIH

10,902 views • 18 days ago

🔬 Big questions can lead to groundbreaking discoveries! Are you ready to explore yours? The NIH Stadtman Tenure-Track Investigator Program gives early-career researchers the funding, resources, and freedom to pursue bold ideas and tackle some of biomedical science’s biggest challenges. 💬 “The program allowed me to explore a lot of creativity and also let my trainees explore a lot of creativity. So, you could have a small idea and build off of that.” - Dr. Kaitlyn Sadtler, Senior Investigator at the National Institute of Biomedical Imaging and Bioengineering. 🔗 Learn more and apply by 9/30:

🔬 Big questions can lead to groundbreaking discoveries! Are you ready to explore yours? The NIH Stadtman Tenure-Track Investigator Program gives early-career researchers the funding, resources, and freedom to pursue bold ideas and tackle some of biomedical science’s biggest challenges. 💬 “The program allowed me to explore a lot of creativity and also let my trainees explore a lot of creativity. So, you could have a small idea and build off of that.” - Dr. Kaitlyn Sadtler, Senior Investigator at the National Institute of Biomedical Imaging and Bioengineering. 🔗 Learn more and apply by 9/30:

NIH

12,454 views • 5 days ago

The NIH wants to hear from you! The NIH Common Fund has issued a request to gather input about scientific opportunities and research challenges for future Common Fund activities! Submit your innovative ideas in biomedical or behavioral research by Sept 19, 2026.

The NIH wants to hear from you! The NIH Common Fund has issued a request to gather input about scientific opportunities and research challenges for future Common Fund activities! Submit your innovative ideas in biomedical or behavioral research by Sept 19, 2026.

NIH

21,880 views • 1 month ago

🏆 ⭐ We're thrilled to announce the 2024 Future of Life Award winners! This year, we honor three groundbreaking experts who laid the foundations for ethics and safety in computing and AI. Learn more about the invaluable work of Batya Friedman, James Moor, and Steve Omohundro:

🏆 ⭐ We're thrilled to announce the 2024 Future of Life Award winners! This year, we honor three groundbreaking experts who laid the foundations for ethics and safety in computing and AI. Learn more about the invaluable work of Batya Friedman, James Moor, and Steve Omohundro:

Future of Life Institute

24,382 views • 1 year ago

Every breakthrough begins with curiosity. Every discovery brings us one step closer to better treatments and brighter futures. Learn more about NIH vision science at

Every breakthrough begins with curiosity. Every discovery brings us one step closer to better treatments and brighter futures. Learn more about NIH vision science at

NIH

20,285 views • 1 month ago

What if scientists knew how to stop or slow the spread of cancer cells to other parts of the body? This process, also known as cancer metastasis, is responsible for the majority of cancer deaths. NIH researchers are studying this process with hopes of preventing it from happening. 🎥 Watch the full video to learn more:

What if scientists knew how to stop or slow the spread of cancer cells to other parts of the body? This process, also known as cancer metastasis, is responsible for the majority of cancer deaths. NIH researchers are studying this process with hopes of preventing it from happening. 🎥 Watch the full video to learn more:

NIH

12,677 views • 3 months ago

Cisplatin is one of the most effective cancer drugs we have — but it comes with a tough tradeoff: permanent hearing loss in up to half of patients who receive it. NIH scientists led by Dr. Lisa Cunningham are testing whether a common cholesterol drug, atorvastatin, can reduce that risk in randomized, placebo-controlled trial. Learn more about the trial:

Cisplatin is one of the most effective cancer drugs we have — but it comes with a tough tradeoff: permanent hearing loss in up to half of patients who receive it. NIH scientists led by Dr. Lisa Cunningham are testing whether a common cholesterol drug, atorvastatin, can reduce that risk in randomized, placebo-controlled trial. Learn more about the trial:

NIH

24,060 views • 18 days ago

Presenting at NIH is more than a milestone. “It’s an exciting opportunity” to showcase innovation, build connections, and collaborate at the “pinnacle of health.” 🎥 Watch how biotech leaders are shaping what’s next.

Presenting at NIH is more than a milestone. “It’s an exciting opportunity” to showcase innovation, build connections, and collaborate at the “pinnacle of health.” 🎥 Watch how biotech leaders are shaping what’s next.

NIH

12,458 views • 4 months ago

Hey, don’t forget to submit that #GI26 abstract! It’s your time to shine and help shape the future of GI cancer care with your #gicsm study in progress or a late-stage clinical trial. Abstracts are due Sept. 9 at 11:59 p.m. (ET). Learn more:

Hey, don’t forget to submit that #GI26 abstract! It’s your time to shine and help shape the future of GI cancer care with your #gicsm study in progress or a late-stage clinical trial. Abstracts are due Sept. 9 at 11:59 p.m. (ET). Learn more:

ASCO

10,215 views • 1 year ago